New Podcast Episode. Human Fetal Tissue: A Legacy of Biomedical Research Contributions
Since the 1930’s research using human fetal tissue has been used in numerous scientific and medical advances that have saved millions of lives, including the development of vaccines and treatments for diseases. Despite its substantial contribution to medicine and science, significant public debate and misinformation persists surrounding the ethical use of human fetal tissue in biomedical research. In this episode, hosted by Martin Pera, PhD, Editor-in-Chief, Stem Cell Reports, we will hear more about this important research and the Society’s longstanding science policy work.
The ISSCR, led by its Public Policy Committee, have been tireless champions and advocates for sound science policy across the globe. This includes advocacy for fetal tissue research and working to inform policymakers and the public on the vast medical applications and advances that have, and will, come from the use of HFT in biomedical research. Towards that end, the ISSCR and the Lawrence Goldstein Policy Fellows have authored a recent paper in Stem Cell Reports entitled, Human Fetal Tissue is Critical for Biomedical Research.
Guests
Justin Brumbaugh, PhD, University of Colorado, USA
Lawrence Goldstein, PhD, University of California, San Diego (Emeritus), USA
Tyler Lamb, JD, International Society for Stem Cell Research, USA
Tamra Lysaght, PhD, University of Sydney, Australia
Lawrence (Larry) Goldstein is a Distinguished Professor Emeritus, Department of Cellular and Molecular Medicine and Director Emeritus of Stem Cell Program at the University of California, San Diego. Dr Goldstein’s laboratory worked to understand molecular transport pathways and their impact on neurodegenerative diseases such as Alzheimer’s. He is a member of the National Academy of Sciences and has a long-standing and impactful history of science policy advocacy which includes serving on the ISSCR’s Policy Committee. Larry has received the Public Service Award from the American Society for Cell Biology and is the namesake for the ISSCR’s Lawrence Goldstein Science Policy Fellowship which is training the next generation of scientists to impact public policy.
Tyler Lamb is the ISSCR’s Director of Policy and leads the Society’s global policy efforts including support for stem cell research and funding and facilitating scientifically informed regulatory decision making.
Tamra Lysaght is an Associate Professor in Health Ethics at the University of Sydney in Australia. She studies bioethics and policy-relevant issues in emerging bioscience and health technologies with an emphasis in stem cells and regenerative medicine. Dr Lysaght is an ISSCR Lawrence Goldstein Science Policy Fellow.
Justin Brumbaugh is an Assistant Professor in Molecular Cellular & Developmental Biology at the University of Colorado Boulder. His research leverages stem cells and induced cell fate change to study early development with a focus on epigenetics and post-transcriptional regulation. Dr, Brumbaugh is also an ISSCR Lawrence Goldstein Science Policy Fellow.
Drs. Brumbaugh, Lysaght, and Goldstein, along with Brian Aguado, are authors of the recently published paper, Human Fetal Tissue is Critical for Biomedical Research, in Stem Cell Reports.